Pronóstico del mercado de subcontratación de asuntos regulatorios de atención médica en Europa hasta 2028: impacto de COVID-19 y análisis regional por tipo de servicio (desarrollo de estrategia científica y regulatoria, redacción médica y científica, eCTD y presentaciones electrónicas, servicios de gestión de datos, servicios de gestión del ciclo de vida, farmacovigilancia, química Servicios de fabricación y controles (CMC), etiquetado reglamentario y servicios de ilustraciones reglamentarias) y usuario final (empresas farmacéuticas, empresas de biotecnología y empresas de dispositivos médicos).
Introducción al mercado
El mercado europeo de subcontratación de asuntos regulatorios sanitarios incluye los mercados consolidados de Alemania, Francia, Italia, España, Reino Unido y El resto de Europa. Se espera que un aumento en las actividades de expansión geográfica por parte de empresas que apuntan a aprobaciones rápidas en los mercados locales sea el factor principal que impulse el crecimiento de este mercado en la región europea. Sin embargo, se espera que la pérdida de control y los avances tecnológicos que conducen a fluctuaciones en los precios obstaculicen el crecimiento del mercado en el período de previsión. Se espera que los cambios en el escenario de reembolso y la presión sobre los precios aumenten la adopción de medidas de ahorro por parte de las empresas farmacéuticas y de dispositivos médicos en Alemania. Se prevé que esto promoverá la deslocalización de la subcontratación de asuntos regulatorios. Las empresas farmacéuticas están subcontratando servicios de asuntos regulatorios para obtener documentos de alta calidad, controlar el costo de I+D y reducir los costos de inversión necesarios para capacitar al equipo de asuntos regulatorios. Además, las empresas farmacéuticas y de dispositivos médicos están subcontratando sus servicios de asuntos regulatorios para diversificar sus actividades comerciales y gestionar los ciclos de vida de los productos. El aumento de la demanda de aprobación rápida de nuevos productos es el factor principal que impulsa el crecimiento del mercado europeo de subcontratación de asuntos regulatorios de atención médica.
Europa ha experimentado un aumento exponencial en los casos de COVID-19. Muchos países de la región registraron una gran cantidad de pacientes por día durante la primera ola. Con el inicio de la segunda ola, se reintrodujeron prohibiciones de reuniones sociales en la segunda mitad de 2020 en el Reino Unido, España, Italia e Irlanda, según el Centro Europeo para la Prevención y el Control de Enfermedades (ECDC). El gobierno ha estado dando prioridad a la mejora de las capacidades de prueba. El aumento exponencial de la tasa de infección está imponiendo una gran carga al sistema de salud de la región, aumentando la demanda de pruebas de diagnóstico en su sistema de salud y apoyando la expansión del sector en esta región. La pandemia de COVID-19 ha provocado retrasos en la investigación y el desarrollo, la fabricación, la cadena de suministro y casi todos los componentes críticos para el desarrollo de fármacos. La comunicación con los reguladores se ha vuelto impredecible debido a los largos tiempos de espera para recibir comentarios de los equipos de revisión o agencias críticas para el proceso de desarrollo. Además, los plazos ajustados y la disponibilidad de personal las 24 horas del día son desafíos particulares que enfrentan los participantes del mercado. Sin embargo, una gran cantidad de ensayos clínicos en curso en respuesta a la pandemia de COVID-19 están contribuyendo al crecimiento del segmento de servicios de ensayos clínicos. La urgencia de identificar y comercializar una cura y una vacuna eficaces para la enfermedad COVID-19 ha aumentado el número de ensayos clínicos en toda Europa. Además, se espera que las medidas regulatorias de apoyo para acortar los tiempos de aprobación de los ensayos, eliminar los períodos de espera, publicar documentos de orientación y financiar los ensayos clínicos impulsen aún más el crecimiento del segmento.
Descripción general del mercado y Dinámica
Se espera que el mercado de subcontratación de asuntos regulatorios de atención médica en Europa crezca de 1.948,90 millones de dólares en 2021 a 3.957,54 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 10,6% de 2021 a 2028. Las actualizaciones continuas y el progreso en los enfoques tradicionales de desarrollo de medicamentos están creando desafíos importantes en el sector de la salud. Existe una tremenda presión sobre las compañías farmacéuticas y la comunidad médica para que reduzcan el costo de los medicamentos recetados, mientras sus costos operativos se están disparando. La complejidad de los requisitos regulatorios, la disminución de los ingresos debido a la pérdida de patente de medicamentos de gran éxito y la presión de los gobiernos y de las aseguradoras de salud para reducir los costos de la atención médica han presentado desafíos adicionales para las industrias de la salud. Dadas estas dificultades, las empresas farmacéuticas se han dado cuenta de la necesidad de aprovechar sus recursos junto con la experiencia proporcionada por fuentes externas especializadas. Muchas empresas de consultoría regulatoria de alto nivel ofrecen su experiencia a lo largo de todo el ciclo de vida del producto. La subcontratación de asuntos regulatorios puede permitir a los patrocinadores ganar experiencia, optimizar costos y mejorar la productividad. Las empresas de subcontratación regulatoria están en mejor posición para evaluar los requisitos regulatorios, lo que les permite seleccionar las mejores soluciones. Están bien versados en la comprensión asociada con la implementación, operación y mantenimiento de un sistema de publicación regulatorio. La mayoría de las grandes empresas farmacéuticas y de biotecnología buscan empresas de consultoría que también puedan ofrecer servicios regulatorios y de farmacovigilancia de apoyo. La creciente complejidad de las presentaciones regulatorias subraya la demanda de experiencia especializada en CRO. Tener planificados consejos y estrategias regulatorias específicas del producto, junto con medidas de cumplimiento regulatorio de atención médica, en las primeras etapas del desarrollo del producto es extremadamente importante para la aprobación regulatoria de los productos. No abordar el cumplimiento en la etapa inicial de desarrollo a menudo conduce a retrasos en el proceso de aprobación debido a documentación presentada incorrectamente, descuidos de fabricación, estudios regulatorios omitidos y otras fallas en el cumplimiento de los requisitos regulatorios. Las empresas de atención médica ahora se están centrando en sus competencias básicas y subcontratando las funciones no esenciales para mejorar la productividad y la eficiencia operativa. Por lo tanto, se espera que la creciente presión regulatoria sobre las empresas de atención médica impulse el crecimiento del mercado.
Segmentos clave del mercado
La atención médica en Europa El mercado de subcontratación de asuntos regulatorios se ha segmentado según el tipo de servicio, el usuario final y el país. Según el tipo de servicio, el mercado europeo de subcontratación de asuntos regulatorios sanitarios se segmenta en servicios médicos y de salud. redacción científica, farmacovigilancia, servicios de gestión de datos, servicios de gestión del ciclo de vida, eCTD y presentaciones electrónicas, desarrollo de estrategias científicas y regulatorias, servicios de fabricación y controles químicos (CMC), etiquetado regulatorio y servicios de arte regulatorio. El médico y El segmento de redacción científica dominó el mercado en 2020 y se espera que el segmento de farmacovigilancia sea el de más rápido crecimiento durante el período de pronóstico. Según el usuario final, el mercado se segmenta en empresas farmacéuticas, empresas de biotecnología y empresas de dispositivos médicos. El segmento de empresas farmacéuticas dominó el mercado en 2020 y se espera que sea el de más rápido crecimiento durante el período previsto. Asimismo, las empresas de dispositivos médicos segmentadas se clasifican en materiales y materiales para dispositivos médicos. biomateriales, dispositivos médicos, biomarcadores y diagnóstico in vitro (IVD), software de dispositivos médicos (SaMD), electromecánica de dispositivos médicos, dispositivos médicos basados en sustancias y dispositivos médicos de productos combinados.
Principales fuentes y empresas enumeradas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de subcontratación de asuntos regulatorios de atención sanitaria en Europa son los sitios web de las empresas, los informes anuales y las finanzas. informes, documentos del gobierno nacional y base de datos estadísticos, entre otros. Las principales empresas que figuran en el informe son Arriello Ireland Ltd., Asphalion SL, Azierta Contract Science Support Consulting, DRA CONSULTING OY, IQVIA Inc., KLIFO, PAREXEL INTERNATIONAL CORPORATION, PHARMALEX GMBH, ProductLife Group, ProPharma Group y Voisin Consulting Life Sciences ( VCLS) son, entre otros.
Informe de razones para comprar
- Comprender el panorama del mercado de subcontratación de asuntos regulatorios de atención sanitaria en Europa e identificar los segmentos del mercado que tienen más probabilidades de garantizar un fuerte retorno
- Manténgase a la vanguardia comprendiendo el Panorama competitivo en constante cambio para el mercado europeo de subcontratación de asuntos regulatorios de atención médica
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado europeo de subcontratación de asuntos regulatorios de atención médica identificando segmentos de mercado con las ventas probables más prometedoras
- Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado de subcontratación de asuntos regulatorios de atención médica en Europa
- Obtener pronósticos de ingresos del mercado para varios segmentos de 2021 a 2028 en la región de Europa.
Segmentación del mercado de subcontratación de asuntos regulatorios sanitarios en Europa
Mercado de subcontratación de asuntos regulatorios de atención médica en Europa: por tipo de servicio
- Médico y sanitario Redacción científica
- Farmacovigilancia
- Servicios de gestión de datos
- Servicios de gestión del ciclo de vida
- eCTD y presentaciones electrónicas
- Desarrollo de estrategias regulatorias y científicas
- Servicios de controles y fabricación química (CMC)
- Etiquetado regulatorio
- Servicios de arte regulatorio
Mercado europeo de subcontratación de asuntos regulatorios sanitarios: por usuario final
- Empresas farmacéuticas
- Empresas de biotecnología
- Empresas de dispositivos médicos
- Materiales y materiales para dispositivos médicos Biomateriales
- Biomarcadores de dispositivos médicos y diagnóstico in vitro (IVD)
- Software de dispositivos médicos (SaMD)
- Electromecánica de dispositivos médicos
- Dispositivo médico Dispositivo médico basado en sustancias
- Producto combinado
Mercado de subcontratación de asuntos regulatorios sanitarios en Europa: por país
- Alemania
- Reino Unido
- Francia
- Italia
- España
- Resto de Europa
Mercado de subcontratación de asuntos regulatorios sanitarios en Europa:Perfiles de empresas
- Arriello Ireland Ltd.
- Asphalion SL
- Azierta Contract Science Support Consulting
- DRA CONSULTING OY
- IQVIA Inc.
- KLIFO
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- Grupo ProPharma
- Voisin Consulting Life Sciences (VCLS)
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Healthcare Regulatory Affairs Outsourcing Market – By Service Type
1.3.2 Europe Healthcare Regulatory Affairs Outsourcing Market – By End User
1.3.3 Europe Healthcare Regulatory Affairs Outsourcing Market – By Country
2. Europe Healthcare Regulatory Affairs Outsourcing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Healthcare Regulatory Affairs Outsourcing Market – Market Landscape
4.1 Overview
4.2 Expert Opinions
5. Europe Healthcare Regulatory Affairs Outsourcing Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Regulatory Pressure on Healthcare Companies
5.1.2 Rise in Demand for Speedy Approval of New Products
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Advancements in Specialty Therapies, Orphan Drugs, and Personalized Medicines
5.4 Future Trends
5.4.1 Surging Market Consolidation Activities
5.5 Impact Analysis
6. Healthcare Regulatory Affairs Outsourcing Market – Europe Analysis
6.1 Europe Healthcare Regulatory Affairs Outsourcing Market Revenue Forecast and Analysis
7. Europe Healthcare Regulatory Affairs Outsourcing Market Analysis – By Service Type
7.1 Overview
7.2 Healthcare Regulatory Affairs Outsourcing Market, by Service Type (2021 and 2028)
7.3 Regulatory and Scientific Strategy Development
7.3.1 Overview
7.3.2 Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Medical and Scientific Writing
7.4.1 Overview
7.4.2 Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 eCTD and E-Submissions
7.5.1 Overview
7.5.2 eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Data Management Services
7.6.1 Overview
7.6.2 Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Life Cycle Management Services
7.7.1 Overview
7.7.2 Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pharmacovigilance
7.8.1 Overview
7.8.2 Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Chemistry Manufacturing and Controls (CMC) Services
7.9.1 Overview
7.9.2 Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Regulatory Labelling
7.10.1 Overview
7.10.2 Regulatory Labelling : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Regulatory Artwork Services
7.11.1 Overview
7.11.2 Regulatory Artwork Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Healthcare Regulatory Affairs Outsourcing Market Analysis – By End User
8.1 Overview
8.2 Healthcare Regulatory Affairs Outsourcing Market, by End-User (2020 and 2028)
8.3 Pharmaceutical Companies
8.3.1 Overview
8.3.2 Pharmaceutical Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Biotechnology Companies
8.4.1 Overview
8.4.2 Biotechnology Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Medical Device Companies
8.5.1 Overview
8.5.2 Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Medical Device Software (SaMD) Market
8.5.2.1.1 Overview
8.5.2.1.2 Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.2 Medical Device Materials & Biomaterials Market
8.5.2.2.1 Overview
8.5.2.2.2 Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.3 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market
8.5.2.3.1 Overview
8.5.2.3.2 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.4 Medical Device Electro mechanics Market
8.5.2.4.1 Overview
8.5.2.4.2 Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.5 Medical Device Substance Based Market
8.5.2.5.1 Overview
8.5.2.5.2 Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.6 Medical Device of Combination Product (DDC) Market
8.5.2.6.1 Overview
8.5.2.6.2 Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
9. Europe Healthcare Regulatory Affairs Outsourcing Market – Country Analysis
9.1.1 Europe Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Country (%)
9.1.1.1 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1.1 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.1.2 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Service Type (US$ Mn)
9.1.1.1.3 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by End User (US$ Mn)
9.1.1.1.3.1 Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by Medical Device Companies (US$ Mn)
9.1.1.2 France Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
9.1.1.2.1 France: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 France Healthcare Regulatory Affairs Outsourcing : Market, By Service Type, 2019–2028 (USD Million)
9.1.1.2.3 France: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.2.3.1 France: Healthcare Regulatory Affairs Outsourcing Market, by Medical Device Companies, 2019–2028 (USD Million)
9.1.1.3 UK: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 UK: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 UK: Contract Research Organization (CRO) Market, By Service Type, 2019–2028 (USD Million)
9.1.1.3.3 UK: Contract Research Organization (CRO) Market, by End User, 2019–2028 (USD Million)
9.1.1.3.3.1 UK: Contract Research Organization (CRO) Market, by Medical Device Companies, 2019–2028 (USD Million)
9.1.1.4 Italy: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Italy: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Italy: Healthcare Regulatory affairs outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.4.3 Italy Healthcare Regulatory affairs outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.4.3.1 Italy: Healthcare Regulatory affairs outsourcing Market, by Medical Device Companies, 2019–2028 (USD Million)
9.1.1.5 Spain: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 Spain: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 Spain: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.5.3 Spain: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.5.3.1 Spain: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.6 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.6.3.1 Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Healthcare Regulatory Affairs Outsourcing Market
10.1 Overview
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 KLIFO
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ProPharma Group
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Arriello Ireland Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 DRA CONSULTING OY
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Asphalion S.L
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 PAREXEL INTERNATIONAL CORPORATION
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 IQVIA Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PHARMALEX GMBH
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 ProductLife Group
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Voisin Consulting Life Sciences (VCLS)
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Azierta Contract Science Support Consulting
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Service Type US$ Mn)
Table 3. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by End User US$ Mn)
Table 4. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, by Medical Device Companies US$ Mn)
Table 5. France: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. France: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 7. France Healthcare Regulatory Affairs Outsourcing Market, by Medical Device Companies– Revenue and Forecast to 2028 (USD Million)
Table 8. UK: Contract Research Organization (CRO) Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. UK: Contract Research Organization (CRO) Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. UK Contract Research Organization (CRO) Market, by Medical Device Companies– Revenue and Forecast to 2028 (USD Million)
Table 11. Italy: Healthcare Regulatory affairs outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Italy: Healthcare Regulatory affairs outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Italy Healthcare Regulatory affairs outsourcing Market, by Medical Device Companies– Revenue and Forecast to 2028 (USD Million)
Table 14. Spain: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 16. Spain Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Europe Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 21. Inorganic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 22. Glossary of Terms, Healthcare Regulatory Affairs Outsourcing Market
LIST OF FIGURES
Figure 1. Europe Healthcare Regulatory Affairs Outsourcing Market Segmentation
Figure 2. Europe Healthcare Regulatory Affairs Outsourcing Market Segmentation, By Country
Figure 3. Europe Healthcare Regulatory Affairs Outsourcing Market Overview
Figure 4. Medical & Scientific Writing Segment Held the Largest Share of the Service Type Segment in Europe Healthcare Regulatory Affairs Outsourcing Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Healthcare Regulatory Affairs Outsourcing Market Impact Analysis of Driver and Restraints
Figure 8. Europe Healthcare Regulatory Affairs Outsourcing Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by Service Type (2020 and 2028)
Figure 10. Europe Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Regulatory Labelling: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Regulatory Artwork Services : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by End-User (2020 and 2028)
Figure 20. Europe Pharmaceutical Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Biotechnology Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Europe Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe: Healthcare Regulatory Affairs Outsourcing Market Revenue Overview, by Country, 2021 (US$ MN)
Figure 30. Europe Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028, By Country (%)
Figure 31. Germany Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 32. France: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. UK: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Italy: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Spain: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Europe: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in European Country Markets
- Arriello Ireland Ltd.
- Asphalion S.L
- Azierta Contract Science Support Consulting
- DRA CONSULTING OY
- IQVIA Inc.
- KLIFO
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- ProPharma Group
- Voisin Consulting Life Sciences (VCLS)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Healthcare Regulatory Affairs Outsourcing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe Healthcare Regulatory Affairs Outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Healthcare Regulatory Affairs Outsourcing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution